Home/Filings/4/0001214659-17-005528
4//SEC Filing

THOMPSON JOHN CRAIG 4

Accession 0001214659-17-005528

CIK 0001316175other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 2:43 PM ET

Size

4.5 KB

Accession

0001214659-17-005528

Insider Transaction Report

Form 4
Period: 2017-09-07
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common stock

    2017-09-07$1.43/sh+10,400$14,89317,590 total

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeother

Related Parties

1
  • filerCIK 0001509643

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 2:43 PM ET
Size
4.5 KB